Cargando…
Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia
Disease relapse from standard chemotherapy in acute myeloid leukemia (AML) is poorly understood. The importance of protein phosphatase 2A (PP2A) as an AML tumor suppressor is emerging. Therefore, here, we examined the potential role of endogenous PP2A inhibitor proteins as biomarkers predicting AML...
Autores principales: | Mäkelä, Eleonora, Löyttyniemi, Eliisa, Salmenniemi, Urpu, Kauko, Otto, Varila, Taru, Kairisto, Veli, Itälä-Remes, Maija, Westermarck, Jukka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895887/ https://www.ncbi.nlm.nih.gov/pubmed/31717978 http://dx.doi.org/10.3390/cancers11111774 |
Ejemplares similares
-
Early CD8(+)-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT
por: Ranti, Juha, et al.
Publicado: (2018) -
Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML
por: Impola, Ulla, et al.
Publicado: (2016) -
Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
por: Salmenniemi, Urpu, et al.
Publicado: (2012) -
CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance
por: Ventelä, Sami, et al.
Publicado: (2014) -
MYC is not detected in highly proliferating normal spermatogonia but is coupled with CIP2A in testicular cancers
por: Ventelä, Sami, et al.
Publicado: (2016)